RxDoctor Payments Data

Erica May

Family · Hickory, NCNPI 1346961562

Payments from drug & device makers

$5,178in general payments, 2019–2025

Across 236 payments — averaging $21.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$515
  • Daiichi Sankyo Inc.$328
  • Merck$282
  • AstraZeneca$282
  • Astellas Pharma US Inc$277
  • Bayer$272
  • plus $3K from 48 others

What the payments were for

  • Food & beverage$4,71091%
  • Education$4699%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,178 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
VenclextaVenetoclax16$147,834
EliquisApixaban51$29,623
Mirtazapine12$227
Ondansetron Hcl19$210
Hydroxyurea16$147
Venlafaxine Hcl ErVenlafaxine Hcl14$119
Prednisone26$106
Doxycycline Hyclate18$91

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVenclexta$71$147,83416 claims
PfizerEliquis$149$29,62351 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.

Other family in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →